Share Price and Basic Stock Data
Last Updated: December 14, 2024, 10:13 am
PEG Ratio | 0.00 |
---|
Competitors of Alchemist Ltd
Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
---|---|---|---|---|---|---|---|---|---|
Gujarat Metallic Coal & Coke Ltd | 5.94 Cr. | 30.0 | / | 77.6 | 0.00 % | 0.37 % | 2.00 % | 100 | |
Gensol Engineering Ltd | 1,107 Cr. | 291 | 1,126/290 | 12.8 | 155 | 0.00 % | 14.3 % | 20.1 % | 10.0 |
Gagan Polycot India Ltd | 0.86 Cr. | 0.86 | / | 4.08 | 0.00 % | 81.2 % | 81.2 % | 10.0 | |
Fusion Micro Finance Ltd | 1,516 Cr. | 150 | 544/140 | 251 | 0.00 % | 14.1 % | 19.6 % | 10.0 | |
Five X Tradecom Ltd | 0.99 Cr. | 0.48 | / | 9.35 | 0.00 % | 0.00 % | 0.00 % | 10.0 | |
Industry Average | 2,413.12 | N/A | 131.82 | N/A | N/A | 20.61 | 61.74 | N/A |
Quarterly Result
Metric | Dec 2012 | Mar 2013 | Jun 2013 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 388 | 360 | 409 | 9 | 6 | 6 | 6 | 6 | 5 | 3 | 1 | 1 | 1 |
Expenses | 375 | 352 | 398 | -9 | 73 | 8 | 8 | 7 | 5 | 4 | 49 | 1 | 373 |
Operating Profit | 12 | 8 | 11 | 18 | -67 | -2 | -2 | -1 | -1 | -1 | -48 | 0 | -372 |
OPM % | 3% | 2% | 3% | 204% | -1,116% | -25% | -43% | -16% | -14% | -52% | -3,731% | 5% | -31,800% |
Other Income | 4 | 8 | 2 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 124 |
Interest | 2 | 3 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation | 3 | 4 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Profit before tax | 12 | 9 | 8 | 16 | -69 | -3 | -4 | -3 | -2 | -3 | -50 | -1 | -250 |
Tax % | 11% | 61% | 30% | -1% | 1% | 10% | -271% | 7% | 8% | -54% | -20% | 12% | -26% |
Net Profit | 10 | 4 | 5 | 16 | -70 | -3 | 7 | -3 | -3 | -1 | -40 | -2 | -186 |
EPS in Rs | 7.54 | 2.70 | 3.95 | 11.59 | -51.46 | -2.22 | 5.48 | -2.16 | -1.89 | -1.08 | -29.33 | -1.15 | -136.88 |
Last Updated: Unknown
Below is a detailed analysis of the quarterly data for Alchemist Ltd based on the most recent figures (Sep 2020) and their trends compared to the previous period:
- For Sales, as of Sep 2020, the value is ₹1.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2020) which recorded 1.00 Cr..
- For Expenses, as of Sep 2020, the value is ₹373.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.00 Cr. (Jun 2020) to ₹373.00 Cr., marking an increase of ₹372.00 Cr..
- For Operating Profit, as of Sep 2020, the value is ₹-372.00 Cr.. The value appears to be declining and may need further review. It has decreased from 0.00 Cr. (Jun 2020) to ₹-372.00 Cr., marking a decrease of 372.00 Cr..
- For OPM %, as of Sep 2020, the value is -31,800.00%. The value appears to be declining and may need further review. It has decreased from 5.00% (Jun 2020) to -31,800.00%, marking a decrease of 31,805.00%.
- For Other Income, as of Sep 2020, the value is ₹124.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Jun 2020) to ₹124.00 Cr., marking an increase of ₹124.00 Cr..
- For Interest, as of Sep 2020, the value is ₹0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2020) which recorded 0.00 Cr..
- For Depreciation, as of Sep 2020, the value is ₹2.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2020) which recorded 2.00 Cr..
- For Profit before tax, as of Sep 2020, the value is ₹-250.00 Cr.. The value appears to be declining and may need further review. It has decreased from -1.00 Cr. (Jun 2020) to ₹-250.00 Cr., marking a decrease of 249.00 Cr..
- For Tax %, as of Sep 2020, the value is -26.00%. The value appears to be improving (decreasing) as expected. It has decreased from 12.00% (Jun 2020) to -26.00%, marking a decrease of 38.00%.
- For Net Profit, as of Sep 2020, the value is ₹-186.00 Cr.. The value appears to be declining and may need further review. It has decreased from -2.00 Cr. (Jun 2020) to ₹-186.00 Cr., marking a decrease of 184.00 Cr..
- For EPS in Rs, as of Sep 2020, the value is -136.88. The value appears to be declining and may need further review. It has decreased from ₹-1.15 (Jun 2020) to -136.88, marking a decrease of ₹135.73.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: March 7, 2025, 9:20 pm
Metric | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 386 | 396 | 503 | 886 | 1,457 | 1,508 | 350 | 105 | 24 | 27 | 27 | 14 | 6 |
Expenses | 355 | 364 | 468 | 852 | 1,417 | 1,475 | 375 | 138 | 53 | 36 | 80 | 65 | 427 |
Operating Profit | 32 | 32 | 35 | 34 | 41 | 33 | -26 | -33 | -29 | -10 | -53 | -51 | -422 |
OPM % | 8% | 8% | 7% | 4% | 3% | 2% | -7% | -32% | -121% | -36% | -199% | -354% | -7,096% |
Other Income | 3 | 3 | 1 | 12 | 16 | 14 | 14 | 13 | -69 | 3 | 1 | 0 | 124 |
Interest | 8 | 7 | 4 | 4 | 7 | 4 | 5 | 5 | 2 | 2 | 1 | 1 | 0 |
Depreciation | 8 | 8 | 10 | 11 | 12 | 15 | 23 | 26 | 8 | 8 | 7 | 7 | 6 |
Profit before tax | 19 | 20 | 22 | 31 | 38 | 28 | -39 | -52 | -108 | -16 | -61 | -58 | -304 |
Tax % | 28% | 22% | 40% | 23% | 25% | 55% | -2% | 3% | -1% | 3% | -18% | -19% | |
Net Profit | 14 | 16 | 13 | 24 | 27 | 12 | -38 | -53 | -107 | -17 | -50 | -47 | -228 |
EPS in Rs | 11.50 | 12.91 | 10.68 | 18.54 | 20.05 | 10.44 | -26.36 | -35.67 | -79.15 | -12.47 | -36.61 | -34.46 | -168.44 |
Dividend Payout % | 17% | 16% | 19% | 22% | 7% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
Year | 2009-2010 | 2010-2011 | 2011-2012 | 2012-2013 | 2013-2014 | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 |
---|---|---|---|---|---|---|---|---|---|---|---|
YoY Net Profit Growth (%) | 14.29% | -18.75% | 84.62% | 12.50% | -55.56% | -416.67% | -39.47% | -101.89% | 84.11% | -194.12% | 6.00% |
Change in YoY Net Profit Growth (%) | 0.00% | -33.04% | 103.37% | -72.12% | -68.06% | -361.11% | 377.19% | -62.41% | 186.00% | -278.23% | 200.12% |
Alchemist Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2009-2010 to 2019-2020.
Growth
Compounded Sales Growth | |
---|---|
10 Years: | -28% |
5 Years: | -47% |
3 Years: | -16% |
TTM: | -74% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | -12% |
3 Years: | -9% |
TTM: | -21246% |
Stock Price CAGR | |
---|---|
10 Years: | -21% |
5 Years: | 25% |
3 Years: | 0% |
1 Year: | % |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
Last Year: | % |
Last Updated: Unknown
Balance Sheet
Last Updated: December 14, 2024, 4:03 pm
Month | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Sep 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 12 | 12 | 12 | 13 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 |
Reserves | 94 | 103 | 81 | 78 | 151 | 122 | 73 | 21 | -97 | -113 | -163 | -210 | -397 |
Borrowings | 151 | 157 | 216 | 342 | 322 | 789 | 721 | 738 | 740 | 752 | 763 | 768 | 764 |
Other Liabilities | 51 | 55 | 85 | 80 | 79 | 233 | 222 | 226 | 178 | 170 | 161 | 161 | 42 |
Total Liabilities | 308 | 327 | 394 | 512 | 566 | 1,159 | 1,030 | 999 | 835 | 822 | 774 | 733 | 422 |
Fixed Assets | 162 | 173 | 193 | 200 | 235 | 276 | 433 | 405 | 162 | 154 | 147 | 140 | 137 |
CWIP | 40 | 45 | 74 | 135 | 201 | 202 | 27 | 19 | 0 | 0 | 0 | 0 | 0 |
Investments | 24 | 24 | 23 | 2 | 2 | 2 | 2 | 2 | 171 | 169 | 169 | 169 | 169 |
Other Assets | 82 | 85 | 104 | 176 | 128 | 679 | 568 | 574 | 503 | 500 | 459 | 424 | 116 |
Total Assets | 308 | 327 | 394 | 512 | 566 | 1,159 | 1,030 | 999 | 835 | 822 | 774 | 733 | 422 |
Below is a detailed analysis of the balance sheet data for Alchemist Ltd based on the most recent figures (Sep 2020) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2020, the value is ₹14.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2020) which recorded ₹14.00 Cr..
- For Reserves, as of Sep 2020, the value is ₹-397.00 Cr.. The value appears to be worsening (becoming more negative). It has deteriorated from ₹-210.00 Cr. (Mar 2020) to ₹-397.00 Cr., marking a decline of 187.00 Cr..
- For Borrowings, as of Sep 2020, the value is ₹764.00 Cr.. The value appears to be improving (decreasing). However, Reserves are negative, which is a major warning sign. It has decreased from ₹768.00 Cr. (Mar 2020) to ₹764.00 Cr., marking a decrease of 4.00 Cr..
- For Other Liabilities, as of Sep 2020, the value is ₹42.00 Cr.. The value appears to be improving (decreasing). It has decreased from ₹161.00 Cr. (Mar 2020) to ₹42.00 Cr., marking a decrease of 119.00 Cr..
- For Total Liabilities, as of Sep 2020, the value is ₹422.00 Cr.. The value appears to be improving (decreasing). It has decreased from ₹733.00 Cr. (Mar 2020) to ₹422.00 Cr., marking a decrease of 311.00 Cr..
- For Fixed Assets, as of Sep 2020, the value is ₹137.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹140.00 Cr. (Mar 2020) to ₹137.00 Cr., marking a decrease of 3.00 Cr..
- For CWIP, as of Sep 2020, the value is ₹0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2020) which recorded ₹0.00 Cr..
- For Investments, as of Sep 2020, the value is ₹169.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2020) which recorded ₹169.00 Cr..
- For Other Assets, as of Sep 2020, the value is ₹116.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹424.00 Cr. (Mar 2020) to ₹116.00 Cr., marking a decrease of 308.00 Cr..
- For Total Assets, as of Sep 2020, the value is ₹422.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹733.00 Cr. (Mar 2020) to ₹422.00 Cr., marking a decrease of 311.00 Cr..
However, the Borrowings (764.00 Cr.) are higher than the Reserves (₹-397.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
Month | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
Month | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow | -119.00 | -125.00 | -181.00 | -308.00 | -281.00 | -756.00 | -747.00 | -771.00 | -769.00 | -762.00 | -816.00 | -819.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
Month | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 16 | 16 | 15 | 11 | 4 | 99 | 495 | 1,732 | 7,098 | 6,471 | 5,807 | 9,597 |
Inventory Days | 26 | 32 | 31 | 17 | 11 | 12 | 56 | 230 | 114 | 36 | 19 | 20 |
Days Payable | 17 | 21 | 10 | 4 | 2 | 38 | 176 | 828 | 2,641 | 2,554 | 2,430 | 4,894 |
Cash Conversion Cycle | 25 | 27 | 36 | 25 | 12 | 73 | 375 | 1,134 | 4,572 | 3,952 | 3,397 | 4,723 |
Working Capital Days | 14 | 16 | -9 | -0 | 7 | 68 | 371 | 1,264 | 4,791 | 4,406 | 3,758 | 5,867 |
ROCE % | 11% | 10% | 9% | 9% | 10% | 5% | -3% | -5% | -5% | -2% | -9% | -10% |
This stock is not held by any mutual fund
Key Financial Ratios
Month | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 |
---|---|---|---|---|---|
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Basic EPS (Rs.) | -34.46 | -36.61 | -12.40 | -79.15 | -35.67 |
Diluted EPS (Rs.) | -34.46 | -36.61 | -12.40 | -79.15 | -35.67 |
Cash EPS (Rs.) | -29.56 | -31.52 | -6.75 | -73.28 | -19.90 |
Book Value[Excl.RevalReserv]/Share (Rs.) | -144.68 | -110.27 | -73.55 | -61.33 | 32.55 |
Book Value[Incl.RevalReserv]/Share (Rs.) | -144.68 | -110.27 | -73.55 | -61.33 | 32.55 |
Revenue From Operations / Share (Rs.) | 10.63 | 19.72 | 19.62 | 17.82 | 77.47 |
PBDIT / Share (Rs.) | -37.45 | -38.59 | -5.70 | -19.41 | -8.26 |
PBIT / Share (Rs.) | -42.35 | -43.68 | -11.42 | -25.28 | -27.61 |
PBT / Share (Rs.) | -42.76 | -44.69 | -12.16 | -80.00 | -38.02 |
Net Profit / Share (Rs.) | -34.46 | -36.61 | -12.47 | -79.15 | -39.25 |
NP After MI And SOA / Share (Rs.) | -34.46 | -36.61 | -12.47 | -79.15 | -35.67 |
PBDIT Margin (%) | -352.38 | -195.73 | -29.03 | -108.90 | -10.66 |
PBIT Margin (%) | -398.50 | -221.54 | -58.21 | -141.84 | -35.63 |
PBT Margin (%) | -402.34 | -226.66 | -61.99 | -448.92 | -49.08 |
Net Profit Margin (%) | -324.24 | -185.66 | -63.57 | -444.13 | -50.66 |
NP After MI And SOA Margin (%) | -324.24 | -185.67 | -63.57 | -444.11 | -46.04 |
Return on Networth / Equity (%) | 0.00 | 0.00 | 0.00 | 0.00 | -140.30 |
Return on Capital Employeed (%) | -10.05 | -9.71 | -2.35 | -5.16 | -4.66 |
Return On Assets (%) | -6.37 | -6.41 | -2.05 | -12.85 | -4.84 |
Long Term Debt / Equity (X) | -3.89 | -5.05 | -7.46 | -8.83 | 20.86 |
Total Debt / Equity (X) | -3.91 | -5.07 | -7.50 | -8.88 | 21.20 |
Asset Turnover Ratio (%) | 0.01 | 0.03 | 0.03 | 0.02 | 0.01 |
Current Ratio (X) | 2.43 | 2.66 | 2.93 | 2.85 | 2.82 |
Quick Ratio (X) | 2.42 | 2.66 | 2.92 | 2.81 | 2.61 |
Inventory Turnover Ratio (X) | 5.98 | 5.87 | 1.31 | 0.19 | 0.30 |
Interest Coverage Ratio (X) | -91.90 | -38.22 | -4.50 | -11.66 | -2.23 |
Interest Coverage Ratio (Post Tax) (X) | -83.56 | -35.26 | -9.27 | -14.68 | -7.79 |
Enterprise Value (Cr.) | 765.56 | 759.40 | 757.00 | 766.59 | 762.63 |
EV / Net Operating Revenue (X) | 53.12 | 28.40 | 28.46 | 31.72 | 7.26 |
EV / EBITDA (X) | -15.07 | -14.51 | -98.01 | -29.13 | -68.09 |
MarketCap / Net Operating Revenue (X) | 0.09 | 0.09 | 0.41 | 1.30 | 0.25 |
Price / BV (X) | -0.01 | -0.01 | -0.11 | -0.37 | 0.78 |
Price / Net Operating Revenue (X) | 0.09 | 0.09 | 0.41 | 1.30 | 0.25 |
EarningsYield | -35.90 | -19.07 | -1.53 | -3.42 | -1.78 |
After reviewing the key financial ratios for Alchemist Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 20, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 19) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 20, the value is -34.46. This value is below the healthy minimum of 5. It has increased from -36.61 (Mar 19) to -34.46, marking an increase of 2.15.
- For Diluted EPS (Rs.), as of Mar 20, the value is -34.46. This value is below the healthy minimum of 5. It has increased from -36.61 (Mar 19) to -34.46, marking an increase of 2.15.
- For Cash EPS (Rs.), as of Mar 20, the value is -29.56. This value is below the healthy minimum of 3. It has increased from -31.52 (Mar 19) to -29.56, marking an increase of 1.96.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 20, the value is -144.68. It has decreased from -110.27 (Mar 19) to -144.68, marking a decrease of 34.41.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 20, the value is -144.68. It has decreased from -110.27 (Mar 19) to -144.68, marking a decrease of 34.41.
- For Revenue From Operations / Share (Rs.), as of Mar 20, the value is 10.63. It has decreased from 19.72 (Mar 19) to 10.63, marking a decrease of 9.09.
- For PBDIT / Share (Rs.), as of Mar 20, the value is -37.45. This value is below the healthy minimum of 2. It has increased from -38.59 (Mar 19) to -37.45, marking an increase of 1.14.
- For PBIT / Share (Rs.), as of Mar 20, the value is -42.35. This value is below the healthy minimum of 0. It has increased from -43.68 (Mar 19) to -42.35, marking an increase of 1.33.
- For PBT / Share (Rs.), as of Mar 20, the value is -42.76. This value is below the healthy minimum of 0. It has increased from -44.69 (Mar 19) to -42.76, marking an increase of 1.93.
- For Net Profit / Share (Rs.), as of Mar 20, the value is -34.46. This value is below the healthy minimum of 2. It has increased from -36.61 (Mar 19) to -34.46, marking an increase of 2.15.
- For NP After MI And SOA / Share (Rs.), as of Mar 20, the value is -34.46. This value is below the healthy minimum of 2. It has increased from -36.61 (Mar 19) to -34.46, marking an increase of 2.15.
- For PBDIT Margin (%), as of Mar 20, the value is -352.38. This value is below the healthy minimum of 10. It has decreased from -195.73 (Mar 19) to -352.38, marking a decrease of 156.65.
- For PBIT Margin (%), as of Mar 20, the value is -398.50. This value is below the healthy minimum of 10. It has decreased from -221.54 (Mar 19) to -398.50, marking a decrease of 176.96.
- For PBT Margin (%), as of Mar 20, the value is -402.34. This value is below the healthy minimum of 10. It has decreased from -226.66 (Mar 19) to -402.34, marking a decrease of 175.68.
- For Net Profit Margin (%), as of Mar 20, the value is -324.24. This value is below the healthy minimum of 5. It has decreased from -185.66 (Mar 19) to -324.24, marking a decrease of 138.58.
- For NP After MI And SOA Margin (%), as of Mar 20, the value is -324.24. This value is below the healthy minimum of 8. It has decreased from -185.67 (Mar 19) to -324.24, marking a decrease of 138.57.
- For Return on Networth / Equity (%), as of Mar 20, the value is 0.00. This value is below the healthy minimum of 15. There is no change compared to the previous period (Mar 19) which recorded 0.00.
- For Return on Capital Employeed (%), as of Mar 20, the value is -10.05. This value is below the healthy minimum of 10. It has decreased from -9.71 (Mar 19) to -10.05, marking a decrease of 0.34.
- For Return On Assets (%), as of Mar 20, the value is -6.37. This value is below the healthy minimum of 5. It has increased from -6.41 (Mar 19) to -6.37, marking an increase of 0.04.
- For Long Term Debt / Equity (X), as of Mar 20, the value is -3.89. This value is below the healthy minimum of 0.2. It has increased from -5.05 (Mar 19) to -3.89, marking an increase of 1.16.
- For Total Debt / Equity (X), as of Mar 20, the value is -3.91. This value is within the healthy range. It has increased from -5.07 (Mar 19) to -3.91, marking an increase of 1.16.
- For Asset Turnover Ratio (%), as of Mar 20, the value is 0.01. It has decreased from 0.03 (Mar 19) to 0.01, marking a decrease of 0.02.
- For Current Ratio (X), as of Mar 20, the value is 2.43. This value is within the healthy range. It has decreased from 2.66 (Mar 19) to 2.43, marking a decrease of 0.23.
- For Quick Ratio (X), as of Mar 20, the value is 2.42. This value exceeds the healthy maximum of 2. It has decreased from 2.66 (Mar 19) to 2.42, marking a decrease of 0.24.
- For Inventory Turnover Ratio (X), as of Mar 20, the value is 5.98. This value is within the healthy range. It has increased from 5.87 (Mar 19) to 5.98, marking an increase of 0.11.
- For Interest Coverage Ratio (X), as of Mar 20, the value is -91.90. This value is below the healthy minimum of 3. It has decreased from -38.22 (Mar 19) to -91.90, marking a decrease of 53.68.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 20, the value is -83.56. This value is below the healthy minimum of 3. It has decreased from -35.26 (Mar 19) to -83.56, marking a decrease of 48.30.
- For Enterprise Value (Cr.), as of Mar 20, the value is 765.56. It has increased from 759.40 (Mar 19) to 765.56, marking an increase of 6.16.
- For EV / Net Operating Revenue (X), as of Mar 20, the value is 53.12. This value exceeds the healthy maximum of 3. It has increased from 28.40 (Mar 19) to 53.12, marking an increase of 24.72.
- For EV / EBITDA (X), as of Mar 20, the value is -15.07. This value is below the healthy minimum of 5. It has decreased from -14.51 (Mar 19) to -15.07, marking a decrease of 0.56.
- For MarketCap / Net Operating Revenue (X), as of Mar 20, the value is 0.09. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 19) which recorded 0.09.
- For Price / BV (X), as of Mar 20, the value is -0.01. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 19) which recorded -0.01.
- For Price / Net Operating Revenue (X), as of Mar 20, the value is 0.09. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 19) which recorded 0.09.
- For EarningsYield, as of Mar 20, the value is -35.90. This value is below the healthy minimum of 5. It has decreased from -19.07 (Mar 19) to -35.90, marking a decrease of 16.83.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Strength | Weakness |
---|---|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Alchemist Ltd:
- Net Profit Margin: -324.24%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -10.05% (Industry Average ROCE: 20.61%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 0% (Industry Average ROE: 61.74%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): -83.56
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.42
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 131.82)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: -3.91
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -324.24%
About the Company - Qualitative Analysis
INDUSTRY | ADDRESS | CONTACT |
---|---|---|
Industry not found | Address not found | Contact not found |
FAQ
What is the latest intrinsic value of Alchemist Ltd?
The latest intrinsic value of Alchemist Ltd as on 06 February 2025 is ₹519.59, which is 17162.13% higher than the current market price of ₹3.01, indicating the stock is undervalued by 17162.13%. The stock has a market capitalization of 4.08 Cr. and recorded a high/low of / during the current fiscal year 2024-2025. As of Sep 2020, the company has reserves of ₹-397 Cr and total liabilities of 422 Cr.
What is the Market Cap of Alchemist Ltd?
The Market Cap of Alchemist Ltd is 4.08 Cr..
What is the current Stock Price of Alchemist Ltd as on 06 February 2025?
The current stock price of Alchemist Ltd as on 06 February 2025 is 3.01.
What is the High / Low of Alchemist Ltd stocks in FY 2024-2025?
In FY 2024-2025, the High / Low of Alchemist Ltd stocks is /.
What is the Stock P/E of Alchemist Ltd?
The Stock P/E of Alchemist Ltd is .
What is the Book Value of Alchemist Ltd?
The Book Value of Alchemist Ltd is 283.
What is the Dividend Yield of Alchemist Ltd?
The Dividend Yield of Alchemist Ltd is 0.00 %.
What is the ROCE of Alchemist Ltd?
The ROCE of Alchemist Ltd is 9.70 %.
What is the ROE of Alchemist Ltd?
The ROE of Alchemist Ltd is %.
What is the Face Value of Alchemist Ltd?
The Face Value of Alchemist Ltd is 10.0.